Pain sensitivity in silent myocardial ischemia
Murray Glusman1, James Coromilas, Crawford W Clark
1Departments of Behavioral Physiology and Biopsychology, New York State Psychiatric Institute, New York, NY, USA Department of Psychiatry, Columbia University College of Physicians and Surgeons and Department of Medicine, Division of Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Pain
|March 1, 1996
Summary
This study investigated silent myocardial ischemia (SMI), finding no evidence that impaired pain sensitivity or endorphin activity causes this condition. Further research is needed to understand SMI
Area of Science:
- Cardiology
- Pain Medicine
- Neuroscience
Background:
- The etiology of silent myocardial ischemia (SMI) remains unclear.
- Leading theories suggest impaired pain sensitivity or enhanced endorphin activity may underlie SMI.
- These hypotheses require rigorous investigation in patient populations.
Purpose of the Study:
- To examine the roles of pain sensitivity and endorphin mechanisms in silent myocardial ischemia.
- To test whether generalized impaired pain sensitivity contributes to SMI.
- To determine if endorphin activity plays a causal role in the pathophysiology of SMI.
Main Methods:
- Compared pain sensitivity using thermal, electrical, and ischemic tests in 13 silent myocardial ischemia (SMI) patients and 20 symptomatic ischemia patients.
- Utilized signal detection theory (SDT) and conventional threshold procedures for pain assessment.
- Administered naloxone or placebo in a double-blind, cross-over design to evaluate endorphin system involvement before pain and exercise tests.
Main Results:
- Somatic pain sensitivity was not found to be impaired in patients with silent myocardial ischemia.
- No evidence supported a causal role for endorphins in the development or manifestation of SMI.
- Pain perception and endorphin function did not differ significantly between silent and symptomatic ischemia groups.
Conclusions:
- Impaired pain sensitivity is unlikely to be a primary cause of silent myocardial ischemia.
- Endorphin mechanisms do not appear to play a significant causal role in SMI.
- Further research should explore alternative hypotheses for the pathogenesis of silent myocardial ischemia.
Related Concept Videos
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:19Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
01:30Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
01:30Angina I: Introduction
Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...